Flagship Pioneering, Inc. is a life sciences venture firm that conceives, creates, resources, and grows first-in-category companies. Founded in 2000, the firm operates across therapeutics, agriculture, and sustainability, with a portfolio that includes Moderna, Generate:Biomedicines, Tessera Therapeutics, Indigo Agriculture, and Seres Therapeutics.
The firm has originated more than 120 scientific ventures, with an aggregate portfolio value exceeding $90 billion. Its ecosystem comprises over 40 companies employing more than 9,000 people. Flagship Pioneering's work in life science innovation and company creation has resulted in over 2,500 patents granted worldwide.
Flagship Pioneering's approach involves identifying novel scientific platforms and building companies around them. The firm's most prominent portfolio company, Moderna, developed one of the first widely deployed mRNA COVID-19 vaccines. The firm's activities span capital investment, company formation, and operational support across its portfolio.
